AbbVievsHarmony Biosciences

ABBV and HRMY stock compared: price, dividend, valuation and results, from SEC filings.

HRMY

Harmony Biosciences Holdings, Inc.

$33.11

Value $1.9B

+0.30%
HRMY's page

AbbVie (ABBV) has a market value of $506B and Harmony Biosciences (HRMY) $1.9B. Over the last year, with dividends, ABBV moved +25.9% and HRMY -2.6%. The P/E is 49.1 for ABBV and 10.7 for HRMY. Dividend yield: ABBV 2.42%, HRMY none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$506B

    HRMY$1.9B

    ABBV is 264 times HRMY

  • Revenue, 12 months

    ABBV$66.0B

    HRMY$989M

    ABBV is 67 times HRMY

  • Net income, 12 months

    ABBV$10.3B

    HRMY$179M

    ABBV is 58 times HRMY

  • Operating margin

    ABBV32.2%

    HRMY22.2%

    10.0 points apart

  • ROIC

    ABBV25.7%

    HRMY15.3%

    10.4 points apart

  • P/E

    ABBV49.1

    HRMY10.7

    ABBV is 4.6 times HRMY

  • Dividend yield

    ABBV2.4%

    HRMY0.0%

    2.4 points apart

  • 5-year return

    ABBV+191.4%

    HRMY-17.5%

    208.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+191.4%

HRMY-17.5%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsHRMYWith dividends
1 year since November 17, 2025+25.9%Price +22.2%-2.6%Price -2.6%
3 years since November 17, 2023+128.7%+31.7% a yearPrice +106.8%+22.8%+7.1% a yearPrice +22.8%
5 years since November 17, 2021+191.4%+23.8% a yearPrice +143.7%-17.5%-3.8% a yearPrice -17.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieHRMYHarmony Biosciences

Valuation

ABBVHRMY
Valuation
Price$286.01$33.11
Market value$506B$1.9B
Enterprise value (EV)$576B$1.3B
P/E49.110.7
P/E, 5-year median57.015.2
P/B–1.8
EV/EBIT27.15.9
Free cash flow yield3.7%16.9%

Results and growth

ABBVHRMY
Results and growth
Revenue, 12 months$66.0B$989M
Net income, 12 months$10.3B$179M
Free cash flow, 12 months$18.9B$323M
Earnings per share, 12 months$5.81$3.03
Revenue growth, year on year8.6%21.5%
Revenue growth a year, past+5.9%over 5 years+40.3%over 5 years
EPS growth a year, past-2.8%over 5 years–

Margins and returns on capital

ABBVHRMY
Margins and returns on capital
Gross margin73.7%74.0%
Operating margin32.2%22.2%
Net margin15.7%18.1%
ROIC25.7%15.3%
ROE–19.1%

Balance sheet

ABBVHRMY
Balance sheet
Cash$10.8B$771M
Total debt$80.9B$155M
Net debt / EBITDA3.2–
Interest cover7.1×17.0×

Dividends and buybacks

ABBVHRMY
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%–
Shareholder yield2.6%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or HRMY

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or Harmony Biosciences?

By market value, AbbVie ($506B) is about 264.1 times Harmony Biosciences ($1.9B), at today's prices.

How did ABBV and HRMY stock do over the last 5 years?

Since November 17, 2021, ABBV's price moved +143.7% and HRMY's -17.5%. With dividends: ABBV +191.4% (+23.8% a year), HRMY -17.5% (-3.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or HRMY?

The dividend yield at today's price is 2.42% for AbbVie and none for Harmony Biosciences. Over the last twelve months they paid $6.92 and – per share.

What is the P/E of ABBV and HRMY?

At today's price, the P/E is 49.1 for ABBV and 10.7 for HRMY. The median of the last five years was 57.0 and 15.2, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or Harmony Biosciences?

Over the last twelve months, the net margin was 15.7% for AbbVie and 18.1% for Harmony Biosciences, and the operating margin 32.2% and 22.2%. Revenue was $66.0B and $989M.

Which is the better investment, AbbVie or Harmony Biosciences?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.